BioSpace News Archive

OBI Pharma, Inc. announced that Amy Huang, General Manager, will present a company overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 9:00 a.m. PST/12 noon EST, in San Francisco, CA.

“I wanted to keep all of my dental-hygiene products in one convenient location,” said an inventor from Lebanon, Pa. “I came up with this idea so that I would have everything I need at my fingertips. It also keeps all of my supplies clean and sanitary to reduce the risk of germs.”

Patent further advances company’s commanding intellectual property position in fibroblast cell treatments

Today, Advantia Health announced two additions to its executive team. Mary Langowski has joined the company’s board of directors and Nathan Barbour has assumed the role of Advantia’s Chief Growth Officer

Company Also Expands Sales, Marketing and R&D Teams

Heisenberg II, a revolutionary technology platform automates and simplifies the challenging and arduous task of physician compensation administration.

Hemp farmers, manufacturers, and business operators across the country are eager to see changes to federal regulation of hemp.

BCF is pleased to announce the appointment of Stuart Kozlick as its Chief of Healthcare Technology Strategies and Business Development, for both startup and growing business clients of the firm.

After 3 years as the official distributor of JCRB cell lines in North America, Sekisui XenoTech has expanded its agreement with the National Institute of Biomedical Innovation to include distribution to Europe.

AWAK Technologies (AWAK), a pioneering medical technology company focused on dialysis using regeneration technology for end-stage renal disease, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.